Naghmeh Bahrami
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Naghmeh Bahrami has a total of 129 co-authors. Here are the top co-authors by number of shared publications:
Abdolreza Mohamadnia
Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
13 shared publications- Abdolreza Mohamadnia
Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
11 shared publications - Mohammad Bayat
Craniomaxillofacial Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
9 shared publications Mohammad Bayat
Craniomaxillofacial Research Center, Tehran University of Medical Sciences, Tehran, Iran
6 shared publicationsSadegh Shirian
Department of Pathology, School of Veterinary Medicine, Shahrekord University, Shahrekord, Iran
4 shared publications- Bahram Jafari
Department of Biomedical Engineering, Amirkabir University of Technology (Tehran Polytechnic), Tehran, Iran
2 shared publications
Latest Publications
- Open Access
- 1 July 2026
- Published by Wolters Kluwer Health in Biomedical and Biotechnology Research Journal
- Vol. 10 (3) , 330-342
Proteomic and Transcriptomic Biomarker Panel for Oral Squamous Cell Carcinoma
Background: Oral squamous cell carcinoma (OSCC) is a major malignancy with poor prognosis and no reliable early detection biomarkers. This study aimed to identify differentially expressed proteins in OSCC tissues and validate selected candidates at the transcript level. Methods: In this cross-sectional observational study, paired tumor and adjacent nontumorous tissues from 30 OSCC patients were analyzed using two-dimensional gel electrophoresis followed by liquid chromatography–tandem mass spectrometry-based proteomics. Selected candidates were evaluated through reverse transcription polymerase chain reaction. Statistical analyses included Chi-square and paired t -tests ( P < 0.05). Effect sizes (Cohen’s d ) and odds ratios (OR) with 95% confidence intervals (CIs) were calculated. Spearman correlations assessed clinicopathological associations. Results: Five candidates-dermcidin (DCD), Serpin Family B Member 1 (leukocyte elastase inhibitor) (SERPINB1), haptoglobin (HP), heat shock protein beta-1 (HSPB1), and alcohol dehydrogenase 1B (ADH1B) were identified. DCD, SERPINB1, HP, and HSPB1 showed significantly higher expression in tumors ( P < 0.001), with fold changes of 3.8–6.3, whereas ADH1B was downregulated (fold change = 0.18, P < 0.001). Effect sizes were large for all (Cohen’s d > 1.5). HP (OR = 16.0, 95% CI: 4.8–52.9) and SERPINB1 (OR = 11.0, 95% CI: 3.4–35.8) showed the strongest associations with tumor status. HP expression correlated with Tumor–node–metastasis TNM stage (ρ =0.42, P = 0.02) and histological grade (ρ = −0.38, P = 0.04). Conclusions: Integrated proteomic and transcriptomic analyses identified five differentially expressed biomarkers in OSCC with large effect sizes and strong associations with malignancy. These findings support further investigation of DCD, SERPINB1, HP, HSPB1, and ADH1B as potential diagnostic and prognostic biomarkers in larger independent cohorts and clinically accessible samples.
- 1 July 2026
- Published by Wolters Kluwer Health in Biomedical and Biotechnology Research Journal
- Vol. 10 (3) , 330-342
Open AccessProteomic and Transcriptomic Biomarker Panel for Oral Squamous Cell Carcinoma
Background: Oral squamous cell carcinoma (OSCC) is a major malignancy with poor prognosis and no reliable early detection biomarkers. This study aimed to identify differentially expressed proteins in OSCC tissues and validate selected candidates at the transcript level. Methods: In this cross-sectional observational study, paired tumor and adjacent nontumorous tissues from 30 OSCC patients were analyzed using two-dimensional gel electrophoresis followed by liquid chromatography–tandem mass spectrometry-based proteomics. Selected candidates were evaluated through reverse transcription polymerase chain reaction. Statistical analyses included Chi-square and paired t -tests ( P < 0.05). Effect sizes (Cohen’s d ) and odds ratios (OR) with 95% confidence intervals (CIs) were calculated. Spearman correlations assessed clinicopathological associations. Results: Five candidates-dermcidin (DCD), Serpin Family B Member 1 (leukocyte elastase inhibitor) (SERPINB1), haptoglobin (HP), heat shock protein beta-1 (HSPB1), and alcohol dehydrogenase 1B (ADH1B) were identified. DCD, SERPINB1, HP, and HSPB1 showed significantly higher expression in tumors ( P < 0.001), with fold changes of 3.8–6.3, whereas ADH1B was downregulated (fold change = 0.18, P < 0.001). Effect sizes were large for all (Cohen’s d > 1.5). HP (OR = 16.0, 95% CI: 4.8–52.9) and SERPINB1 (OR = 11.0, 95% CI: 3.4–35.8) showed the strongest associations with tumor status. HP expression correlated with Tumor–node–metastasis TNM stage (ρ =0.42, P = 0.02) and histological grade (ρ = −0.38, P = 0.04). Conclusions: Integrated proteomic and transcriptomic analyses identified five differentially expressed biomarkers in OSCC with large effect sizes and strong associations with malignancy. These findings support further investigation of DCD, SERPINB1, HP, HSPB1, and ADH1B as potential diagnostic and prognostic biomarkers in larger independent cohorts and clinically accessible samples.
- Open Access
- 27 November 2025
- Published by Springer Nature in Journal of Biological Engineering
- Vol. 19 (1) , 107
Exosome-functionalized collagen-coated 3D-printed PCL scaffold for enhanced osteogenic differentiation and bone regeneration: an in vitro and in vivo study
Background: Bone tissue engineering offers a promising strategy to overcome the limitations of conventional bone grafts, including donor site morbidity and immune rejection. In this study, three-dimensional (3D) polycaprolactone (PCL) scaffolds coated with collagen (Col) were fabricated by extrusion-based printing. The scaffolds were further functionalized with human endometrial mesenchymal stem cells (hEnMSCs) and osteoblast-derived exosomes (ODExo), obtained from osteoblast-like cells, to investigate their potential in bone regeneration. Results: The printed scaffolds exhibited controlled porosity, suitable mechanical integrity, and improved hydrophilicity following collagen coating. ODExo were isolated from osteoblast-like cells and confirmed by morphology and particle size. In vitro analyses revealed that exosome-functionalized scaffolds significantly enhanced cell adhesion, proliferation, and osteogenic differentiation of hEnMSCs, as indicated by increased calcium deposition and elevated expression of osteogenic markers such as alkaline phosphatase, osteocalcin, RUNX2, and osteonectin, even without osteogenic induction medium. In vivo experiments using a rat calvarial defect model demonstrated superior bone formation and matrix mineralization in scaffolds containing exosomes compared with control groups. Moreover, transplantation of PCL/Col scaffolds seeded with hEnMSCs and ODExo implants further promoted bone regeneration in vivo. Conclusions: These findings demonstrate that osteoblast-derived exosomes serve as potent bioactive modulators capable of driving osteogenic differentiation and accelerating bone regeneration. Incorporating exosomes into 3D printed PCL/Col scaffolds provides a promising biomimetic and partially cell-free approach for the treatment of critical-sized bone defects. This strategy highlights the potential of combining advanced scaffold fabrication with bioactive vesicles to improve clinical outcomes in regenerative medicine. Graphical
- 27 November 2025
- Published by Springer Nature in Journal of Biological Engineering
- Vol. 19 (1) , 107
Open AccessExosome-functionalized collagen-coated 3D-printed PCL scaffold for enhanced osteogenic differentiation and bone regeneration: an in vitro and in vivo study
Background: Bone tissue engineering offers a promising strategy to overcome the limitations of conventional bone grafts, including donor site morbidity and immune rejection. In this study, three-dimensional (3D) polycaprolactone (PCL) scaffolds coated with collagen (Col) were fabricated by extrusion-based printing. The scaffolds were further functionalized with human endometrial mesenchymal stem cells (hEnMSCs) and osteoblast-derived exosomes (ODExo), obtained from osteoblast-like cells, to investigate their potential in bone regeneration. Results: The printed scaffolds exhibited controlled porosity, suitable mechanical integrity, and improved hydrophilicity following collagen coating. ODExo were isolated from osteoblast-like cells and confirmed by morphology and particle size. In vitro analyses revealed that exosome-functionalized scaffolds significantly enhanced cell adhesion, proliferation, and osteogenic differentiation of hEnMSCs, as indicated by increased calcium deposition and elevated expression of osteogenic markers such as alkaline phosphatase, osteocalcin, RUNX2, and osteonectin, even without osteogenic induction medium. In vivo experiments using a rat calvarial defect model demonstrated superior bone formation and matrix mineralization in scaffolds containing exosomes compared with control groups. Moreover, transplantation of PCL/Col scaffolds seeded with hEnMSCs and ODExo implants further promoted bone regeneration in vivo. Conclusions: These findings demonstrate that osteoblast-derived exosomes serve as potent bioactive modulators capable of driving osteogenic differentiation and accelerating bone regeneration. Incorporating exosomes into 3D printed PCL/Col scaffolds provides a promising biomimetic and partially cell-free approach for the treatment of critical-sized bone defects. This strategy highlights the potential of combining advanced scaffold fabrication with bioactive vesicles to improve clinical outcomes in regenerative medicine. Graphical
- Open Access
- 27 October 2025
- Published by Maad Rayan Publishing Company in Journal of lasers in medical sciences
- Vol. 16, e49
Effect of Photobiomodulation Therapy with Three Wavelengths of Diode Laser on Proliferation and Survival of Stem Cells Derived from Impacted Third Molar Follicles
Introduction: Increased tissue regeneration is facilitated by mesenchymal stem cells (MSCs), with photobiomodulation (PBM) effectively promoting their proliferation. This study examines the impact of PBM on human third molar follicle stem cells using three diode lasers, addressing the need for further investigation regarding its parameters. Methods: The third molar follicle stem cells of four consented patients were removed after surgical extraction of third molars. These cells were then exposed to laser radiation with wavelengths of 660 (energy density: 3 and 5.1 J/cm2), 808 (energy density: 3 and 5 J/cm 2), and 980 (energy density: 3.2 and 5/2 J/cm 2) nanometers at time intervals of 24, 48, and 72 hours. The proliferation and viability of the cells were determined using the MTT test. The data were analyzed through one-way ANOVA followed by Tukey’s HSD post hoc test, utilizing SPSS software version 22, with a significance threshold of 0.05. Results: The highest average number of human third molar follicle stem cells was obtained at 660 nanometers and an energy density of 5.1 J/cm2 in 24 hours. This specific laser protocol significantly outperformed other conditions in promoting cellular proliferation. Conclusion: PBM at the 660-nm wavelength administered with a dose of 5.1 J/cm2 and a 24-hour incubation period appears to be the most effective condition for enhancing the proliferation and survival of human third molar follicle stem cells. These findings provide a potential basis for standardized PBM protocols in regenerative dentistry.
- 27 October 2025
- Published by Maad Rayan Publishing Company in Journal of lasers in medical sciences
- Vol. 16, e49
Open AccessEffect of Photobiomodulation Therapy with Three Wavelengths of Diode Laser on Proliferation and Survival of Stem Cells Derived from Impacted Third Molar Follicles
Introduction: Increased tissue regeneration is facilitated by mesenchymal stem cells (MSCs), with photobiomodulation (PBM) effectively promoting their proliferation. This study examines the impact of PBM on human third molar follicle stem cells using three diode lasers, addressing the need for further investigation regarding its parameters. Methods: The third molar follicle stem cells of four consented patients were removed after surgical extraction of third molars. These cells were then exposed to laser radiation with wavelengths of 660 (energy density: 3 and 5.1 J/cm2), 808 (energy density: 3 and 5 J/cm 2), and 980 (energy density: 3.2 and 5/2 J/cm 2) nanometers at time intervals of 24, 48, and 72 hours. The proliferation and viability of the cells were determined using the MTT test. The data were analyzed through one-way ANOVA followed by Tukey’s HSD post hoc test, utilizing SPSS software version 22, with a significance threshold of 0.05. Results: The highest average number of human third molar follicle stem cells was obtained at 660 nanometers and an energy density of 5.1 J/cm2 in 24 hours. This specific laser protocol significantly outperformed other conditions in promoting cellular proliferation. Conclusion: PBM at the 660-nm wavelength administered with a dose of 5.1 J/cm2 and a 24-hour incubation period appears to be the most effective condition for enhancing the proliferation and survival of human third molar follicle stem cells. These findings provide a potential basis for standardized PBM protocols in regenerative dentistry.
- Open Access
- 18 August 2025
- Published by Springer Nature in The Egyptian Journal of Bronchology
- Vol. 19 (1) , 1-5
Real-time PCR technique for diagnosing respiratory diseases: miR-155, miR-17, miR-181 expression, and COPD
Background and objective: Chronic obstructive pulmonary disease (COPD) is a progressive inflammatory condition with limited noninvasive biomarkers for diagnosis and monitoring. Circulating microRNAs (miRNAs), due to their involvement in inflammation, oxidative stress, and tissue remodeling, offer potential as molecular biomarkers. This study aimed to compare the expression of miR-155, miR-17, and miR-181 in COPD patients versus healthy individuals to assess their diagnostic value. Methods: This cross-sectional study enrolled 30 COPD patients and 30 age- and sex-matched healthy controls. Peripheral blood samples were collected in EDTA tubes, and the total RNA was extracted using the RNeasy Midi Kit (Qiagen). cDNA synthesis was performed using the ZIST ROYESH kit, and expression levels were quantified by SYBR Green-based real-time PCR. U6 snRNA served as the reference gene, and expression was calculated using the 2^-ΔΔCt method. Ct ≤ 35 was considered positive. Results: miR-181 and miR-155 were significantly upregulated in COPD patients with 2.18-fold and 2.32-fold increases, respectively (p < 0.001). Positive expression was detected in 83.3% and 66.7% of patients, respectively. In contrast, miR-17 was downregulated (0.49-fold; p < 0.001) and positive in only 23.3% of patients compared to 80% of controls. No significant differences in age or sex were observed between groups. Conclusion: Distinct expression profiles of miR-155, miR-17, and miR-181 were observed in COPD patients, highlighting their potential as noninvasive biomarkers. miR-181 showed the highest diagnostic sensitivity, whereas miR-17 downregulation may reflect remodeling activity. Combined miRNA profiling could enhance COPD diagnosis and stratification.
- 18 August 2025
- Published by Springer Nature in The Egyptian Journal of Bronchology
- Vol. 19 (1) , 1-5
Open AccessReal-time PCR technique for diagnosing respiratory diseases: miR-155, miR-17, miR-181 expression, and COPD
Background and objective: Chronic obstructive pulmonary disease (COPD) is a progressive inflammatory condition with limited noninvasive biomarkers for diagnosis and monitoring. Circulating microRNAs (miRNAs), due to their involvement in inflammation, oxidative stress, and tissue remodeling, offer potential as molecular biomarkers. This study aimed to compare the expression of miR-155, miR-17, and miR-181 in COPD patients versus healthy individuals to assess their diagnostic value. Methods: This cross-sectional study enrolled 30 COPD patients and 30 age- and sex-matched healthy controls. Peripheral blood samples were collected in EDTA tubes, and the total RNA was extracted using the RNeasy Midi Kit (Qiagen). cDNA synthesis was performed using the ZIST ROYESH kit, and expression levels were quantified by SYBR Green-based real-time PCR. U6 snRNA served as the reference gene, and expression was calculated using the 2^-ΔΔCt method. Ct ≤ 35 was considered positive. Results: miR-181 and miR-155 were significantly upregulated in COPD patients with 2.18-fold and 2.32-fold increases, respectively (p < 0.001). Positive expression was detected in 83.3% and 66.7% of patients, respectively. In contrast, miR-17 was downregulated (0.49-fold; p < 0.001) and positive in only 23.3% of patients compared to 80% of controls. No significant differences in age or sex were observed between groups. Conclusion: Distinct expression profiles of miR-155, miR-17, and miR-181 were observed in COPD patients, highlighting their potential as noninvasive biomarkers. miR-181 showed the highest diagnostic sensitivity, whereas miR-17 downregulation may reflect remodeling activity. Combined miRNA profiling could enhance COPD diagnosis and stratification.
- Open Access
- 20 May 2025
- Published by Springer Nature in Journal of Biological Engineering
- Vol. 19 (1) , 48
Enhancing in vitro osteogenic differentiation of mesenchymal stem cells via sustained dexamethasone delivery in 3D-Printed hybrid scaffolds based on polycaprolactone-nanohydroxyapatite/alginate-gelatin for bone regeneration
Despite the natural ability of bone repair, its limitations have led to advanced organic-inorganic-based biomimetic scaffolds and sustained drug release approaches. Particularly, dexamethasone (DEX), a widely used synthetic glucocorticoid, has been shown to increase the expression of bone-related genes during the osteogenesis process. This study aims to develop a hybrid 3D-printed scaffold for controlled delivery of dexamethasone. Hence, hybrid scaffolds were fabricated using a layer-by-layer 3D-printing of combined materials comprising polycaprolactone (PCL)-nanohydroxyapatite (nHA) composite, and DEX-loaded PCL microparticles embedded in the alginate-gelatin hydrogel. Encapsulation efficiency, loading capacity, and in vitro kinetics of DEX release were evaluated. Osteogenic differentiation of human endometrial mesenchymal stem cells (hEnMSCs) on DEX-loaded hybrid scaffolds was assessed by evaluating osteogenic gene expression levels (collagen I, osteonectin, RUNX2), alkaline phosphatase (ALP) activity, and scaffold mineralization. The hybrid scaffolds exhibited favorable morphology, mechanical-properties, biocompatibility, and biodegradability, enhancing osteogenesis of hEnMSCs. DEX-loaded PCL microparticles within hybrid scaffolds exhibited a controlled release pattern and promoted osteogenic differentiation during the sustained release period through a significant increase in osteonectin and COL1A1 expression. Also, increased mineralization was demonstrated by SEM and alizarin red staining. This study proposes that drug-loaded 3D-printed hybrid organic-inorganic nanocomposite scaffolds are promising for advanced bone tissue engineering applications.
- 20 May 2025
- Published by Springer Nature in Journal of Biological Engineering
- Vol. 19 (1) , 48
Open AccessEnhancing in vitro osteogenic differentiation of mesenchymal stem cells via sustained dexamethasone delivery in 3D-Printed hybrid scaffolds based on polycaprolactone-nanohydroxyapatite/alginate-gelatin for bone regeneration
Despite the natural ability of bone repair, its limitations have led to advanced organic-inorganic-based biomimetic scaffolds and sustained drug release approaches. Particularly, dexamethasone (DEX), a widely used synthetic glucocorticoid, has been shown to increase the expression of bone-related genes during the osteogenesis process. This study aims to develop a hybrid 3D-printed scaffold for controlled delivery of dexamethasone. Hence, hybrid scaffolds were fabricated using a layer-by-layer 3D-printing of combined materials comprising polycaprolactone (PCL)-nanohydroxyapatite (nHA) composite, and DEX-loaded PCL microparticles embedded in the alginate-gelatin hydrogel. Encapsulation efficiency, loading capacity, and in vitro kinetics of DEX release were evaluated. Osteogenic differentiation of human endometrial mesenchymal stem cells (hEnMSCs) on DEX-loaded hybrid scaffolds was assessed by evaluating osteogenic gene expression levels (collagen I, osteonectin, RUNX2), alkaline phosphatase (ALP) activity, and scaffold mineralization. The hybrid scaffolds exhibited favorable morphology, mechanical-properties, biocompatibility, and biodegradability, enhancing osteogenesis of hEnMSCs. DEX-loaded PCL microparticles within hybrid scaffolds exhibited a controlled release pattern and promoted osteogenic differentiation during the sustained release period through a significant increase in osteonectin and COL1A1 expression. Also, increased mineralization was demonstrated by SEM and alizarin red staining. This study proposes that drug-loaded 3D-printed hybrid organic-inorganic nanocomposite scaffolds are promising for advanced bone tissue engineering applications.
- Open Access
- 1 April 2025
- Published by EpiSmart Science Vector Ltd in Asian Pacific Journal of Cancer Prevention
- Vol. 26 (4) , 1225-1231
The Role of Oral Microbiota in the Development of Oral Squamous Cell Carcinoma Using MicroRNA and Apoptosis-Related Gene Expression: An Exploratory Study
Background and Objective: Oral cancer is one of the malignant tumors of the head and neck region, which is associated with high mortality rates and has various negative effects on the aesthetics of patients. Therefore, access to high-quality care for early detection and appropriate surgical and drug treatments is crucial. To this end, researchers are investigating the mechanisms of carcinogenesis in cells and identifying the factors that affect it. The aim of this study was to investigate the mechanisms by which oral microbiota contributes to carcinogenesis. Materials and Methods: Sixty peripheral blood samples were collected from oral squamous cell carcinoma (OSCC) patients with (30 samples) and without (30 samples) of oral infection, referred to the Cancer Institute of Tehran University of Medical Sciences. Real-time PCR was performed to determine the expression levels of miR-92, miR-26, miR-486, Bak, Bax, and Caspase-8 genes. Results: MiR-92 and miR-26 relative expression were higher in the OSCC patients with oral infection compared to OSCC patients without oral infection. However, relative expression of miR-486, Bak, Bax, and Caspase-8 was significantly decreased in patients with oral infection compared to OSCC patients without oral infection. Conclusion: The results showed that oral microbiome prevents apoptosis and promotes the development of cancerous tissue in OSCC patients. The identification of a link between oral infection and microRNA and apoptosis-related gene expression could provide researchers with the opportunity to formulate innovative methods for the prevention or management of OSCC.
- 1 April 2025
- Published by EpiSmart Science Vector Ltd in Asian Pacific Journal of Cancer Prevention
- Vol. 26 (4) , 1225-1231
Open AccessThe Role of Oral Microbiota in the Development of Oral Squamous Cell Carcinoma Using MicroRNA and Apoptosis-Related Gene Expression: An Exploratory Study
Background and Objective: Oral cancer is one of the malignant tumors of the head and neck region, which is associated with high mortality rates and has various negative effects on the aesthetics of patients. Therefore, access to high-quality care for early detection and appropriate surgical and drug treatments is crucial. To this end, researchers are investigating the mechanisms of carcinogenesis in cells and identifying the factors that affect it. The aim of this study was to investigate the mechanisms by which oral microbiota contributes to carcinogenesis. Materials and Methods: Sixty peripheral blood samples were collected from oral squamous cell carcinoma (OSCC) patients with (30 samples) and without (30 samples) of oral infection, referred to the Cancer Institute of Tehran University of Medical Sciences. Real-time PCR was performed to determine the expression levels of miR-92, miR-26, miR-486, Bak, Bax, and Caspase-8 genes. Results: MiR-92 and miR-26 relative expression were higher in the OSCC patients with oral infection compared to OSCC patients without oral infection. However, relative expression of miR-486, Bak, Bax, and Caspase-8 was significantly decreased in patients with oral infection compared to OSCC patients without oral infection. Conclusion: The results showed that oral microbiome prevents apoptosis and promotes the development of cancerous tissue in OSCC patients. The identification of a link between oral infection and microRNA and apoptosis-related gene expression could provide researchers with the opportunity to formulate innovative methods for the prevention or management of OSCC.
- Open Access
- 30 December 2024
- Published by Brieflands in International Journal of Cancer Management
- Vol. 17 (1)
Differential Expression of miR-192, miR-221, miR-15 Among the Nodule Tissues of Sarcoidosis and Lung Cancer
Background: Patients with sarcoidosis were found to have a higher risk of lung cancer compared to the general population. Being aware of all possible associations between these two diseases and identification of biomarkers such as miRNA profiles can be helpful in differentiating the mechanisms of these two diseases, which can aid in clinical decision-making. Methods: The aim of the study was to investigate the expression of selected miRNAs (miR-192 miR-221, miR-15) in lymph nodes of patients with pulmonary sarcoidosis, non-small cell lung carcinomas (NSCLC) and control group (n = 30 per groups) by qRT-PCR. Results: Relative expression of miR-221 in sarcoidosis and NSCC patients was higher than in the control group. Furthermore, the relative expression of miR-15 in patients with sarcoidosis and NSCLC tissue was lower than in the control group. Interestingly, miR-192 is differentially expressed in sarcoidosis and NSCLC patients compared to the control group. Conclusions: The obtained results suggest that the studied miRNAs may have potential diagnostic and therapeutic implications, but further research is necessary to fully understand their roles in these diseases.
- 30 December 2024
- Published by Brieflands in International Journal of Cancer Management
- Vol. 17 (1)
Open AccessDifferential Expression of miR-192, miR-221, miR-15 Among the Nodule Tissues of Sarcoidosis and Lung Cancer
Background: Patients with sarcoidosis were found to have a higher risk of lung cancer compared to the general population. Being aware of all possible associations between these two diseases and identification of biomarkers such as miRNA profiles can be helpful in differentiating the mechanisms of these two diseases, which can aid in clinical decision-making. Methods: The aim of the study was to investigate the expression of selected miRNAs (miR-192 miR-221, miR-15) in lymph nodes of patients with pulmonary sarcoidosis, non-small cell lung carcinomas (NSCLC) and control group (n = 30 per groups) by qRT-PCR. Results: Relative expression of miR-221 in sarcoidosis and NSCC patients was higher than in the control group. Furthermore, the relative expression of miR-15 in patients with sarcoidosis and NSCLC tissue was lower than in the control group. Interestingly, miR-192 is differentially expressed in sarcoidosis and NSCLC patients compared to the control group. Conclusions: The obtained results suggest that the studied miRNAs may have potential diagnostic and therapeutic implications, but further research is necessary to fully understand their roles in these diseases.
- Open Access
- 7 November 2024
- Published by Brieflands in International Journal of Cancer Management
- Vol. 17 (1)
Expression of Five Important Biomarkers in Non-small Cell Lung Cancer: MicroRNAs-128, miR-335-5p, miR-1254, VEGF, and K-RAS
Background: Lung cancers, such as non-small cell lung cancer (NSCLC), are the most common malignancy and leading cause of cancer-related death worldwide. MicroRNAs (miRNAs) play a role in the occurrence of lung cancer by targeting both tumor suppressor genes and oncogenes. Among them, miR-128, miR-335-5p, and miR-1254 are mainly reported to function in regulating lung cancer cell behavior. Objectives: The aim of the study was to investigate the existence and expression levels of miRNA-128, miR-335-5p, and miR-1254 as well as mRNA and protein expression levels of VEGF and mRNA expression levels of K-RAS in both peripheral blood and cancerous tissue of NSCLC patients compared to the healthy subjects. Methods: Blood and tissue samples were collected from 50 healthy donors and 50 NSCLS patients. The serum level of VEGF was measured using the commercial enzyme-linked immunosorbent assay (ELISA). The mRNA expression levels of K-RAS and VEGF, as well as the expression of miRNA-128, miR-335-5p, and miR-1254, were determined, using real-time PCR. Results: Lower mRNA expression levels of miRNA-128, miR-335-5p, and miR-1254, as well as higher mRNA expression levels of VEGF and K-RAS, were detected in both peripheral blood and tissue samples from NSCLC patients compared to those of the healthy subjects. The VEGF protein levels in the peripheral blood of the patients were also found to be significantly lower than those in the healthy subjects. Conclusions: The findings from this study suggest that miR-335-5p, miR-1254, and miR-128, may contribute to the pathogenesis and tumorigenesis of NSCLC at least in part by modulation of proliferation, migration, and angiogenesis via targeting VEGF and K-RAS signaling pathways. K-RAS and VEGF may be target genes for miR-335-5p, miR-1254, and miR-128 in NSCLC patients.
- 7 November 2024
- Published by Brieflands in International Journal of Cancer Management
- Vol. 17 (1)
Open AccessExpression of Five Important Biomarkers in Non-small Cell Lung Cancer: MicroRNAs-128, miR-335-5p, miR-1254, VEGF, and K-RAS
Background: Lung cancers, such as non-small cell lung cancer (NSCLC), are the most common malignancy and leading cause of cancer-related death worldwide. MicroRNAs (miRNAs) play a role in the occurrence of lung cancer by targeting both tumor suppressor genes and oncogenes. Among them, miR-128, miR-335-5p, and miR-1254 are mainly reported to function in regulating lung cancer cell behavior. Objectives: The aim of the study was to investigate the existence and expression levels of miRNA-128, miR-335-5p, and miR-1254 as well as mRNA and protein expression levels of VEGF and mRNA expression levels of K-RAS in both peripheral blood and cancerous tissue of NSCLC patients compared to the healthy subjects. Methods: Blood and tissue samples were collected from 50 healthy donors and 50 NSCLS patients. The serum level of VEGF was measured using the commercial enzyme-linked immunosorbent assay (ELISA). The mRNA expression levels of K-RAS and VEGF, as well as the expression of miRNA-128, miR-335-5p, and miR-1254, were determined, using real-time PCR. Results: Lower mRNA expression levels of miRNA-128, miR-335-5p, and miR-1254, as well as higher mRNA expression levels of VEGF and K-RAS, were detected in both peripheral blood and tissue samples from NSCLC patients compared to those of the healthy subjects. The VEGF protein levels in the peripheral blood of the patients were also found to be significantly lower than those in the healthy subjects. Conclusions: The findings from this study suggest that miR-335-5p, miR-1254, and miR-128, may contribute to the pathogenesis and tumorigenesis of NSCLC at least in part by modulation of proliferation, migration, and angiogenesis via targeting VEGF and K-RAS signaling pathways. K-RAS and VEGF may be target genes for miR-335-5p, miR-1254, and miR-128 in NSCLC patients.
- Open Access
- 9 June 2024
- Published by Brieflands in Jundishapur Journal of Microbiology
- Vol. 17 (5)
IP-10, MIP1α, IL-6, and IL-1β as Biomarkers Associated with Disease Severity of COVID-19
Background: The factors responsible for the progression of COVID-19 from a mild illness to a severe and often lethal condition, characterized by respiratory failure and multiple organ involvement, remain unclear. The identification of biomarkers capable of predicting disease progression is of the highest importance. Objectives: This study sought to assess laboratory measurements of interferon-gamma inducible protein-10 (IP-10), macrophage inflammatory protein 1-alpha (MIP1α), interleukin-6 (IL-6), and interleukin-1 beta (IL-1β) to achieve this objective. Methods: We measured IP-10 and MIP1α by qRT-PCR and IL-6 and IL-1β using an enzyme-linked immunosorbent assay in 120 serum samples. We analyzed differences between patients with moderate, severe, and recovered COVID-19. Results: The number of positive cases for biomarkers IP-10, MIP1α, IL-6, and IL-1β were significantly different between groups. The expression levels of IP-10 and MIP1α were significantly higher in patients with severe COVID-19 compared to those who had recovered. A strong positive association was observed between IP-10 and MIP1α in severe infection cases. Additionally, these biomarkers were relatively independent predictors of disease severity. Conclusions: The results suggest that IP-10, MIP1α, IL-6, and IL-1β are promising research candidates for understanding the severity of COVID-19 and for investigating possible pathophysiological mechanisms of the disease.
- 9 June 2024
- Published by Brieflands in Jundishapur Journal of Microbiology
- Vol. 17 (5)
Open AccessIP-10, MIP1α, IL-6, and IL-1β as Biomarkers Associated with Disease Severity of COVID-19
Background: The factors responsible for the progression of COVID-19 from a mild illness to a severe and often lethal condition, characterized by respiratory failure and multiple organ involvement, remain unclear. The identification of biomarkers capable of predicting disease progression is of the highest importance. Objectives: This study sought to assess laboratory measurements of interferon-gamma inducible protein-10 (IP-10), macrophage inflammatory protein 1-alpha (MIP1α), interleukin-6 (IL-6), and interleukin-1 beta (IL-1β) to achieve this objective. Methods: We measured IP-10 and MIP1α by qRT-PCR and IL-6 and IL-1β using an enzyme-linked immunosorbent assay in 120 serum samples. We analyzed differences between patients with moderate, severe, and recovered COVID-19. Results: The number of positive cases for biomarkers IP-10, MIP1α, IL-6, and IL-1β were significantly different between groups. The expression levels of IP-10 and MIP1α were significantly higher in patients with severe COVID-19 compared to those who had recovered. A strong positive association was observed between IP-10 and MIP1α in severe infection cases. Additionally, these biomarkers were relatively independent predictors of disease severity. Conclusions: The results suggest that IP-10, MIP1α, IL-6, and IL-1β are promising research candidates for understanding the severity of COVID-19 and for investigating possible pathophysiological mechanisms of the disease.
- Open Access
- 9 February 2024
- Published by Brieflands in Jundishapur Journal of Microbiology
- Vol. 17 (1)
Evaluation of Chemokines and Cytokines as Biomarkers for Disease Severity in COVID-19-Infected Patients
Background: Alterations in cytokine and chemokine levels during SARS-CoV-2 infection may serve as indicators of disease severity. Objectives: This study aimed to evaluate the levels of plasma cytokines and chemokines in patients with COVID-19. Methods: The study included 120 COVID-19 patients, divided into severe, mild, and recovered categories (n = 40 for each group). Plasma levels of cytokines such as interleukin 8 (IL-8) and tumor necrosis factor α (TNF-α) were measured using ELISA, while chemokines like monocyte chemoattractant protein 1 (MCP-1) and programmed death protein 1 (PD-1) were quantified through qRT-PCR. Results: A higher incidence of positive biomarkers IL-8, TNF-α, MCP-1, and PD-1 was observed in the severe group compared to the mild and recovered groups. Notably, the expression levels of PD-1 and MCP-1 were significantly elevated in severely infected individuals relative to those in healthy subjects. A strong positive correlation was also noted between PD-1 and MCP-1 levels in cases of severe infection. Conclusions: The findings suggest that MCP-1, PD-1, TNF-α, and IL-8 could act as biomarkers for assessing the severity of COVID-19 infections. These results aim to deepen our understanding of the immunopathological mechanisms at play in this disease.
- 9 February 2024
- Published by Brieflands in Jundishapur Journal of Microbiology
- Vol. 17 (1)
Open AccessEvaluation of Chemokines and Cytokines as Biomarkers for Disease Severity in COVID-19-Infected Patients
Background: Alterations in cytokine and chemokine levels during SARS-CoV-2 infection may serve as indicators of disease severity. Objectives: This study aimed to evaluate the levels of plasma cytokines and chemokines in patients with COVID-19. Methods: The study included 120 COVID-19 patients, divided into severe, mild, and recovered categories (n = 40 for each group). Plasma levels of cytokines such as interleukin 8 (IL-8) and tumor necrosis factor α (TNF-α) were measured using ELISA, while chemokines like monocyte chemoattractant protein 1 (MCP-1) and programmed death protein 1 (PD-1) were quantified through qRT-PCR. Results: A higher incidence of positive biomarkers IL-8, TNF-α, MCP-1, and PD-1 was observed in the severe group compared to the mild and recovered groups. Notably, the expression levels of PD-1 and MCP-1 were significantly elevated in severely infected individuals relative to those in healthy subjects. A strong positive correlation was also noted between PD-1 and MCP-1 levels in cases of severe infection. Conclusions: The findings suggest that MCP-1, PD-1, TNF-α, and IL-8 could act as biomarkers for assessing the severity of COVID-19 infections. These results aim to deepen our understanding of the immunopathological mechanisms at play in this disease.